Practice of construction safety supervision on the stage I and II B bidding works of TGP

被引：0
|
作者：
Yang, Tian-Min
Li, Pu-Jing
He, Hua-Qiang
机构：
来源：
Renmin Changjiang/Yangtze River | 2002年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] SAFETY AND TOLERABILITY OF NEBIVOLOL IN SENIORS AND NON-SENIORS WITH STAGE I-II HYPERTENSION
    Germino, F. W.
    Rowe, W.
    GERONTOLOGIST, 2010, 50 : 42 - 43
  • [22] The milestones in patient safety The Harvard Medical Practice Study I, Study II and Study III
    La Torre, Giuseppe
    Mannocci, Alice
    Agostinelli, Alessandro
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2005, 2 (3-4) : 91 - 92
  • [23] Safety I to Safety II: A Paradigm Shift or More Work as Imagined? Comment on "False Dawns and New Horizons in Patient Safety Research and Practice"
    Smith, Kelly M.
    Valenta, Annette L.
    INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2018, 7 (07): : 671 - 673
  • [24] HODGKIN DISEASE CLINICAL STAGE-I, STAGE-II, AND STAGE-III (A,B) - RESULTS OF RADIOTHERAPY WITH OR WITHOUT CHEMOTHERAPY
    PATRICIO, MB
    RICARDO, JA
    VILHENA, M
    BRANCO, F
    DEPONTE, MA
    CABRAL, R
    NEVES, M
    DESOUSA, JV
    JOURNAL OF SURGICAL ONCOLOGY, 1983, 24 (03) : 236 - 241
  • [25] Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial
    Verstovsek, Srdan
    Foltz, Lynda
    Gupta, Vikas
    Hasserjian, Robert
    Manshouri, Taghi
    Mascarenhas, John
    Mesa, Ruben
    Pozdnyakova, Olga
    Ritchie, Ellen
    Veletic, Ivo
    Gamel, Katia
    Hamidi, Habib
    Han, Lyrialle
    Higgins, Brian
    Trunzer, Kerstin
    Uguen, Marianne
    Wang, Dao
    El-Galaly, Tarec Christoffer
    Todorov, Boyan
    Gotlib, Jason
    HAEMATOLOGICA, 2023, 108 (10) : 2730 - 2742
  • [26] A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma
    de Jonge, A. V.
    Bult, J. A. A.
    Karssing, D. F. E.
    Nijland, M.
    Chamuleau, M. E. D.
    Brink, M.
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [27] A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma
    A. V. de Jonge
    J. A. A. Bult
    D. F. E. Karssing
    M. Nijland
    M. E. D. Chamuleau
    M. Brink
    Blood Cancer Journal, 14
  • [28] Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis
    Chen, Jing
    Wang, Rui
    Zhang, Bo
    Lin, Xingguang
    Wei, Juncheng
    Jia, Yao
    Yin, Ye
    Ye, Shuangmei
    Zhu, Tao
    Chen, Gang
    Yuan, Yongxun
    Lu, Weiguo
    Li, Kezhen
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (04) : 460.e1 - 460.e13
  • [29] Barriers, Bottlenecks, and Challenges in Implementing Safety I- and Safety II-Enabled Safe Systems of Working in Construction Projects: A Scoping Review
    Sarvari, Hadi
    Edwards, David J.
    Rillie, Iain
    Roberts, Chris
    BUILDINGS, 2025, 15 (03)
  • [30] HODGKINS-DISEASE, CLINICAL STAGE-I, STAGE-II-A-B AND STAGE-IIIA - RESULTS OF BRIEF CHEMOTHERAPY FOLLOWED BY IRRADIATION
    FERME, C
    LEPAGE, E
    DAGAY, MF
    BRICE, P
    CASTAIGNE, S
    FERMAND, JP
    FRIJA, J
    MIOT, C
    BROUET, JC
    MARTY, M
    BOIRON, M
    GISSELBRECHT, C
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1992, 34 (03): : 247 - 255
12345